Illumina stock forecast.

In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Illumina and its promising trajectory, we have …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Illumina share forecasts, stock quote and buy / sell signals below. According to present data Illumina's ILMN shares and potentially its market environment have been in bearish cycle last 12 months (if exists). GH Stock 12 Months Forecast. $46.93. (101.59% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Guardant Health in the last 3 months. The average price target is $46.93 with a high forecast of $64.00 and a low forecast of $27.00. The average price target represents a 101.59% change from the last price of $23.28.Detailed Financial Results for Illumina. Our earnings reports, supplementary data, 10Q and 10K, and selected other documents are available below by quarter. Please reach out to our Investor Relations team at [email protected] if you have questions.Delivering Value to Investors. A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the …

Illumina stock plunged to its lowest point in three months Tuesday after the gene-sequencing giant issued a disappointing outlook for 2023. ... The company also forecast adjusted earnings of $1.25 ...Stocks making the biggest moves premarket: Illumina, First Republic, Seagen and more Published Mon, Mar 13 2023 8:14 AM EDT Updated Mon, Mar 13 2023 8:14 AM EDT Pia Singh @pia_singh_

Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

May 15, 2023 at 6:01 AM · 3 min read. Let's talk about the popular Illumina, Inc. ( NASDAQ:ILMN ). The company's shares received a lot of attention from a substantial price movement on the ...The average price target for Illumina is $135.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $260.00 ,the lowest forecast is $50.00. The average price target represents 32.91% Increase from the current price of $101.57.13 ene 2023 ... Recently, the company provided a frail outlook for 2023, with sales expected to be between $4.90 and $5.03 billion, aligning with the consensus ...Dec 1, 2023 · Illumina Inc Stock Forecast and Price Target. According to fourteen experts, who recently provided their 2023 price targets for Illumina Inc, the average price target is $140.00, with a high estimate of $260.00 and a low estimate of $50.00. That is a potential upside of approximately 37.32% from the last closing price of $101.95 on November, 2023. Get today's stock prices, news and investor discussion about Illumina Inc (NDAQ:ILMN). Research ILMN stock prices, stock quotes, stock trends and price ...

According to 8 analyst offering 12-month price targets in the last 3 months, Illumina has an average price target of $230.0 with a high of $300.00 and a low of $150.00. Below is a summary of how ...

Analyzing the anticipated performance of Illumina, the ceiling value that the stock is expected to reach in 2024 stands at a promising $159.52.Indicating a bullish trend, an upside potential of 22.33% signals profitable prospects, with an average monthly return of 1.6%, beckoning investors to consider amplifying their portfolios.

July 10, 2023 — 12:15 am EDT. Illumina stock (NASDAQ: ILMN) currently trades at $187 per share, roughly 51% below its level in March 2021, and it can see solid returns over time. ILMN saw its ...The reduction in workforce commenced on June 21 and will result in charges of about $25 to $35 million, the company said, with majority incurred in the second quarter. Illumina's core global ...Oct 7, 2022 · We believe that Illumina stock (NASDAQ NDAQ +0.9%: ILMN), a gene sequencing company, is currently a better pick than Thermo Fisher Scientific stock (NYSE: TMO), given Illumina’s ILMN 0.0% better ... Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus …Earnings tumbled 81% and lagged forecasts for 26 cents. Sales fell 7% in constant currency. Analysts called for $1.07 billion in sales. ... Illumina Stock Tumbles As Sales, Profits Decline — Why ...ILMN Description — Illumina Inc. ... (ranked lower than approx. 100% of all stocks covered) Analysts Forecast: ILMN Price Target Based on data provided by Zacks Investment Research via Quandl.com. ILMN — Performance: PARTNER NEWS: Thu, Nov 16, 5:49 AM, Zacks10 Agu 2023 ... During its second-quarter earnings report on Wednesday, Illumina lowered its financial outlook for fiscal year 2023 and is now only expecting ...

Illumina expects full-year adjusted profit per share to be between $0.75 and $0.90, compared with its prior forecast of $1.25 to $1.50. The outlook reflects a tax expense impact of about $75 million.A high-level overview of Illumina, Inc. (ILMN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Q4 2023 EPS Estimate Trends. Current. $0.25. 1 Month Ago. $0.27. 3 Months Ago. $0.72. Illumina Inc. analyst estimates, including ILMN earnings per share estimates and analyst recommendations.The Stock Market’s Reaction To The New Illumina CEO. ... CEO coincides with a crucial juncture for the biotech company, as the company also recently revised its full-year forecast, citing a ...Jan 17, 2023 · Illumina stock (NASDAQ: ILMN) saw a significant 53% fall in the last twelve months, underperforming the broader S&P500 index, down 16%. Even in the longer term, ILMN stock is down 38% from levels ...

Illumina's future is looking a bit dim at the moment. Illumina 's ( ILMN 0.59%) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and ...ILMN Illumina Options Ahead of Earnings Analyzing the options chain and the chart patterns of ILMN Illumina prior to the earnings report this week, I would consider purchasing the 195usd strike price Calls with an expiration date of 2023-9-15, for a premium of approximately $8.15. If these options prove to be profitable prior to the earni Analyzing …

Buy Illumina Stock. Illumina Inc (ILMN) is a publicly traded diagnostics & research business based in the US. It opened the day at $95.99 after a previous close of $95.2. During the day the price has varied from a low of $92.69 to a high of $96.2. The latest price was $94.32 (25 minute delay). Illumina is listed on the NASDAQ and employs 11,500 ...HSBC Adjusts Price Target on Illumina to $235 From $270 Aug. 14: MT JPMorgan Adjusts Illumina Price Target to $190 From $235, Maintains Neutral Rating Aug. 10: MT Citigroup Adjusts Illumina's Price Target to $150 From $180, Keeps Sell Rating Aug. 10Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...Dec 1, 2023 · ILMN Earnings Date and Information. Illumina last posted its earnings data on November 9th, 2023. The life sciences company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.20. The company had revenue of $1.12 billion for the quarter, compared to analysts' expectations of $1.13 billion. Rivian Automotive's stock (RIVN) rose in the intraday levels, touching the resistance of the 50-day SMA, while trading alongside the downward secondary trend line in the short term, with negative signals from the RSI after reaching overbought levels, doubling negative pressures on the stock.Illumina stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. Calendar News. Markets. Commodities; Currencies; Stocks; ... Looking ahead, we forecast Illumina to be priced at 96.04 by the end of this quarter and at 89.45 in one year, according to Trading Economics global macro models ...Oct 26, 2023 · Analyzing the anticipated performance of Illumina, the ceiling value that the stock is expected to reach in 2026 stands at a promising $159.52.Indicating a bullish trend, an upside potential of 22.33% signals profitable prospects, with an average monthly return of 0.59%, beckoning investors to consider amplifying their portfolios. Illumina Stock Is the Worst Performer in the S&P 500. Grail Isn’t the Only Issue. Illumina stock was falling sharply Friday after the gene-sequencing company slashed its financial forecasts ...

View the latest Moderna Inc. (MRNA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

214.60%. Get the latest Illumina, Inc. (ILMN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Jan 17, 2023 · Illumina stock (NASDAQ: ILMN) saw a significant 53% fall in the last twelve months, underperforming the broader S&P500 index, down 16%. Even in the longer term, ILMN stock is down 38% from levels ... HUM Stock 12 Months Forecast. $588.80. (18.91% Upside) Based on 15 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $588.80 with a high forecast of $640.00 and a low forecast of $550.00. The average price target represents a 18.91% change from the last price of $495.18.SAN DIEGO, July 18, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the second quarter 2023 following the close of market on Wednesday, August 9, 2023.. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Charles Dadswell, Interim Chief Executive Officer and General Counsel, and …According to the issued ratings of 17 analysts in the last year, the consensus rating for Illumina stock is Hold based on the current 3 sell ratings, 7 hold ratings and 7 buy ratings for ILMN. The average twelve-month price prediction for Illumina is $194.56 with a high price target of $328.00 and a low price target of $100.00.Dec 1, 2023 · Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus rating of Hold and a price target of $217.47, up 99.1% from its current price of $109.22. See the latest news, analysis, and earnings reports for Illumina on MarketBeat. The all-time high Illumina stock closing price was 524.84 on August 16, 2021. The Illumina 52-week high stock price is 238.55, which is 117.3% above the current ...Find the latest Illumina, Inc. (ILMN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceGet a real-time Illumina, Inc. (ILMN) stock price quote with breaking news, financials, statistics, charts and more. ... The 12-month stock price forecast is $200.33 ...Part of deSouza's pay bump is a special grant of stock options worth $12.5 million, which Illumina called a "meaningful retention incentive in a highly competitive talent environment."Illumina generated revenue of $2.75 billion last year, and the company is on track to make around $3.3 billion in 2018. Within the next 10 years, Illumina's market should be much bigger. It doesn ...Dec 1, 2023 · ILMN Earnings Date and Information. Illumina last posted its earnings data on November 9th, 2023. The life sciences company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.20. The company had revenue of $1.12 billion for the quarter, compared to analysts' expectations of $1.13 billion. The Company's common stock is traded on the NASDAQ Stock Market under the symbol ILMN. ... At what price? Illumina went public on July 28, 2000 at a price of ...

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022. February 7, 2023. Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis. Revenue of $4.58 billion for fiscal year 2022, up 1% from fiscal year 2021, and up 3% on a constant currency basis.ILMN Earnings Date and Information. Illumina last posted its earnings data on November 9th, 2023. The life sciences company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.20. The company had revenue of $1.12 billion for the quarter, compared to analysts' expectations of $1.13 billion.Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings: According to 11 analyst offering 12-month price targets in the last 3 months, Illumina has an average ...Stock Price Forecast. The 17 analysts offering 12-month price forecasts for Coupang Inc have a median target of 21.00, with a high estimate of 30.00 and a low estimate of 11.60. The median ...Instagram:https://instagram. which broker is best for option tradingfuture trade platformaaa renters insurance pricexly top 25 holdings Find real-time MRNA - Moderna Inc stock quotes, company profile, news and forecasts from CNN Business.Find the latest analyst research for Illumina, Inc. Common Stock (ILMN) at Nasdaq.com. is bed bath and beyond now overstocktd ameritrade switch to margin account Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued the following response to Carl Icahn's public statements and letters to Illumina's ... tbil stock dividend Analyzing the anticipated performance of Illumina, the ceiling value that the stock is expected to reach in 2024 stands at a promising $159.52.Indicating a bullish trend, an upside potential of 22.33% signals profitable prospects, with an average monthly return of 1.6%, beckoning investors to consider amplifying their portfolios.(See CRSP stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus …